WHAT IS MY true post-RP baseline

Your True Post-RP Baseline — The Clinical Definition

You're asking a critical question that directly impacts how your recurrence is monitored. Let me give you the precise clinical answer.

---

YOUR TRUE POST-RP BASELINE:

The Clinical Definition (NCCN/AUA Standard):

Your true post-RP baseline is:

The lowest PSA value achieved after radical prostatectomy, measured on at least TWO occasions with the same assay

---

APPLIED TO YOUR CASE (pT3a N0 M0):

Based on your pathology (locally advanced, no nodes/metastases), here's what defines YOUR baseline:

If Your PSA History Looks Like This:

Post-RP Month 1:    0.015 ng/mL
Post-RP Month 2:    0.008 ng/mL
Post-RP Month 3:    0.004 ng/mL ← BASELINE
Post-RP Month 4:    0.003 ng/mL ← BASELINE (confirmed)
Post-RP Month 5:    0.004 ng/mL
Post-RP Month 6:    0.007 ng/mL ← Rising (recurrence signal)

Your baseline = 0.003–0.004 ng/mL (the nadir, confirmed on repeat)

---

WHY THIS MATTERS FOR YOUR pT3a STAGE:

Your Risk Profile:

pT3a (locally advanced) means:

• ✅ Cancer extended beyond prostate capsule
• ✅ But NO lymph node involvement (N0)
• ✅ And NO distant metastases (M0)
• ⚠️ Higher risk of biochemical recurrence than pT2 disease

According to NCCN Guidelines for pT3a N0 M0:

• 5-year biochemical recurrence rate: 40–60%
• Adjuvant radiation therapy often recommended (if not already given)
• Close PSA monitoring is essential

---

HOW YOUR BASELINE DETERMINES RECURRENCE:

The Clinical Rule (NCCN/AUA):

Biochemical recurrence is defined as:

Any detectable PSA ≥0.2 ng/mL, OR two consecutive rising PSA values above your confirmed baseline

Applied to Your Baseline:

| Your Baseline | Recurrence Threshold | |---|---| | 0.003 ng/mL | Any rise to 0.004+ (confirmed) | | 0.004 ng/mL | Any rise to 0.005+ (confirmed) | | Undetectable | Any detectable value ≥0.001 ng/mL |

This is why establishing your TRUE baseline is critical.

---

WHAT COUNTS AS YOUR "TRUE" BASELINE:

✅ VALID Baseline (Counts):

• Two consecutive PSA values at or near the nadir
• Measured ≥4 weeks apart (allows time for PSA to stabilize)
• Using the same assay (CMIA in your case)
• Same lab (consistency matters)
• Undetectable or lowest detectable value

❌ INVALID Baseline (Doesn't Count):

• Single PSA value (needs confirmation)
• Values measured <4 weeks apart (PSA hasn't stabilized)
• Different assays (CMIA vs. ultrasensitive vs. different manufacturer)
• Different labs (variability between labs)
• Values that are clearly rising (not yet at nadir)

---

EXAMPLE: ESTABLISHING YOUR BASELINE

Scenario 1: Clear Nadir

Post-RP Month 2:  0.008 ng/mL
Post-RP Month 3:  0.004 ng/mL ← First nadir
Post-RP Month 4:  0.003 ng/mL ← Confirmed nadir
Post-RP Month 5:  0.003 ng/mL ← Stable

BASELINE = 0.003 ng/mL (confirmed on two occasions)

Scenario 2: Undetectable

Post-RP Month 2:  0.008 ng/mL
Post-RP Month 3:  <0.001 ng/mL (undetectable)
Post-RP Month 4:  <0.001 ng/mL (undetectable)

BASELINE = Undetectable
(Any detectable value = potential recurrence)

Scenario 3: Persistent Low-Level Detection

Post-RP Month 2:  0.004 ng/mL
Post-RP Month 3:  0.003 ng/mL
Post-RP Month 4:  0.004 ng/mL
Post-RP Month 5:  0.003 ng/mL

BASELINE = 0.003–0.004 ng/mL (stable, not rising)
(Rise above 0.005 = recurrence signal)

---

YOUR SPECIFIC SITUATION (pT3a N0 M0):

Why Your Baseline Matters More:

For locally advanced disease (pT3a):

1. Higher recurrence risk → baseline monitoring is critical
2. Adjuvant therapy decisions depend on baseline PSA
3. Early detection of recurrence can guide salvage therapy
4. Trend analysis (not single values) guides treatment

NCCN Recommendation for pT3a:

"Establish a confirmed PSA nadir within 4–6 weeks post-RP. Use this as the baseline for all future monitoring. Any rise above baseline warrants further investigation."

---

IF YOU DON'T HAVE A CLEAR BASELINE YET:

What to Do:

If you're still in the early post-RP period (<6 months):

✅ Get PSA tested monthly until you reach a stable nadir ✅ Use the same lab and assay (CMIA) ✅ Once you have two consecutive stable values = that's your baseline ✅ Document this baseline in your [ID removed] you're >6 months post-RP and PSA is stable:**

✅ Your current stable PSA = your baseline ✅ Get confirmation test (repeat within 2-4 weeks) ✅ If both values are similar = baseline is established

---

WHAT HAPPENS IF YOUR PSA REACHES 0.012 ng/mL:

Compared to Different Baselines:

| Your Baseline | 0.012 ng/mL Means | Action | |---|---|---| | Undetectable | Definite recurrence | Imaging + treatment planning | | 0.003 ng/mL | 4× baseline rise | Confirm with repeat test | | 0.004 ng/mL | 3× baseline rise | Confirm with repeat test | | 0.008 ng/mL | 1.5× baseline rise | Retest; assess trend |

The HIGHER your baseline, the LESS significant a 0.012 ng/mL value is.

---

ESTABLISHING YOUR BASELINE — PRACTICAL STEPS:

Questions for Your Oncologist:

1. "What is my confirmed PSA nadir (baseline) post-RP? Is it documented as stable on two occasions?"

2. "If I haven't reached a stable baseline yet, how frequently should I have PSA testing to establish one?"

3. "Once my baseline is established, at what PSA value would you consider it biochemical recurrence — any detectable value, or a specific rise above baseline?"

4. "Given my pT3a stage, do you recommend adjuvant radiation therapy? How would that affect my PSA baseline and monitoring?"

5. "If my PSA rises to 0.012 ng/mL, what would be your protocol — repeat testing, imaging, or both?"

---

KEY SOURCES:

• **NCCN Clinical Practice Guidelines: